Walleye Capital’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-383,591
| Closed | -$32M | – | 2516 |
|
|
2024
Q4 | $32M | Buy |
383,591
+134,203
| +54% | +$11.2M | 0.08% | 69 |
|
|
2024
Q3 | $18.2M | Buy |
249,388
+13,601
| +6% | +$995K | 0.04% | 126 |
|
|
2024
Q2 | $16.1M | Buy |
235,787
+80,649
| +52% | +$5.52M | 0.03% | 147 |
|
|
2024
Q1 | $10.7M | Buy |
+155,138
| New | +$10.7M | 0.02% | 240 |
|
|
2023
Q4 | – | Sell |
-134,655
| Closed | -$7.01M | – | 3136 |
|
|
2023
Q3 | $7.01M | Buy |
+134,655
| New | +$7.01M | 0.02% | 307 |
|
|
2023
Q2 | – | Sell |
-226,402
| Closed | -$12.3M | – | 2965 |
|
|
2023
Q1 | $12.3M | Buy |
226,402
+16,690
| +8% | +$904K | 0.18% | 105 |
|
|
2022
Q4 | $11.1M | Buy |
209,712
+4,149
| +2% | +$220K | 0.2% | 103 |
|
|
2022
Q3 | $9.57M | Buy |
205,563
+108,153
| +111% | +$5.03M | 0.18% | 115 |
|
|
2022
Q2 | $5.56M | Buy |
97,410
+27,691
| +40% | +$1.58M | 0.15% | 146 |
|
|
2022
Q1 | $4.27M | Buy |
69,719
+51,841
| +290% | +$3.17M | 0.11% | 180 |
|
|
2021
Q4 | $936K | Sell |
17,878
-86,547
| -83% | -$4.53M | 0.03% | 620 |
|
|
2021
Q3 | $3.89K | Buy |
104,425
+16,772
| +19% | +$625 | 0.11% | 114 |
|
|
2021
Q2 | $3.58K | Buy |
87,653
+23,599
| +37% | +$963 | 0.12% | 123 |
|
|
2021
Q1 | $2.17K | Sell |
64,054
-1,346
| -2% | -$46 | 0.13% | 120 |
|
|
2020
Q4 | $2.08K | Buy |
+65,400
| New | +$2.08K | 0.14% | 112 |
|
|
2020
Q1 | – | Sell |
-41,068
| Closed | -$1.41M | – | 1011 |
|
|
2019
Q4 | $1.41M | Buy |
41,068
+22,768
| +124% | +$781K | 0.09% | 78 |
|
|
2019
Q3 | $137K | Buy |
+18,300
| New | +$137K | 0.01% | 249 |
|
|
2019
Q2 | – | Sell |
-7,605
| Closed | -$92K | – | 963 |
|
|
2019
Q1 | $92K | Buy |
+7,605
| New | +$92K | 0.02% | 163 |
|